Comparing two pacing methods for heart failure patients
Official title: Conduction System Pacing Versus Biventricular Pacing for Heart Failure Patients With Right Ventricular Pacing Upgraded to Cardiac Resynchronization Therapy: a Prospective Multicenter Non-inferiority Randomized Controlled Study
Run by The First Affiliated Hospital with Nanjing Medical University · NCT06241651 · Data updated 2026-11-12
This study is testing whether a new pacing method called conduction system pacing can help heart failure patients just as much as the standard biventricular pacing to improve their heart function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | The First Affiliated Hospital with Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT06241651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-80 with symptomatic heart failure and a left ventricular ejection fraction (LVEF) of less than 50% after at least 3 months of right ventricular pacing.
✕Probably not a fit
Patients with a history of acute myocardial infarction, significant arrhythmias, or other serious cardiac conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of conduction system pacing (CSP) compared to biventricular pacing (BiVP) in heart failure patients who have been upgraded from right ventricular pacing (RVP) to cardiac resynchronization therapy (CRT). It is a multicenter, non-inferiority, randomized controlled trial designed to determine if CSP is as effective as BiVP in improving cardiac function. The study focuses on patients with symptomatic heart failure and aims to address the issues caused by RVP, which can lead to heart function deterioration. By comparing these two pacing methods, the study seeks to provide insights into the best treatment options for this patient population.
Why it matters
Potential benefit: If successful, this study could provide a more effective pacing method for heart failure patients, potentially improving their quality of life and cardiac function.
How similar studies have gone: While CSP has been gaining traction globally, this study is novel as it specifically compares CSP and BiVP in the context of heart failure patients upgraded from RVP.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with symptomatic heart failure (LVEF \<50%) after right ventricular pacing for at least 3 months; 2. NYHA class II-IV; 3. NT-proBNP \>125pg/mL in patients with sinus rhythm, NT-proBNP \>250pg/mL in patients with atrial fibrillation; 4. Right ventricular pacing percentage \>40%; 5. Adult patients aged 18-80; 6. With informed consent signed. Exclusion Criteria: 1. History of acute myocardial infarction within 3 months before enrollment; 2. Frequent premature ventricular contraction (\>15%) or malignant ventricular arrhythmia which is difficult to control; 3. History of valvular heart disease intervention within 3 months before enrollment; 4. After mechanical tricuspid valve replacement; 5. Ventricular septal hypertrophy (≥15mm during diastole); 6. Complex congenital heart disease; 7. History of heart transplantation; 8. Enrollment in any other study; 9. Pregnant or with child-bearing plan; 10. A life expectancy of less than 12 months.
Where it's running
-
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Jiangang Zou
- Email: jgzou@njmu.edu.cn
- Phone: 86-13605191407
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
Conduction system pacing vs biventricular pacing for CRT
This study tests whether pacing the heart’s conduction system (HIS or left bundle) during CRT works better than standard biventricular pacing for people with heart failure.
-
Comparing two pacemaker pacing methods for AV block
This trial tests whether conduction system (left bundle branch area) pacing or standard right ventricular pacing works better for people with atrioventricular block who need a permanent pacemaker.
-
Pacing decisions guided by risk for pacing-induced heart muscle weakness
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing two pacing methods for heart failure treatment
This study is testing which pacing method, conduction system pacing or biventricular pacing, works better for people with heart failure to see if it can help them live longer and avoid hospital visits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.